There may be good news on the horizon for MS (Multiple Sclerosis) sufferers. A recent trial, HALT MS, shows great promise for those experiencing the relapsing-remitting form of the disease, the most common type.
Sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) and the National Institutes of Health (NIH), HALT MS involved 24 participants. While MS sufferers have varied symptoms, participants in this study were those suffering from the relapsing-remitting form of the disease and who in spite of traditional treatments were still experiencing active inflammation.
The treatment involved high-dose immunosuppressive therapy followed by hematopoietic cell transplant (HDIT/HCT). The desired outcome was to suppress the active disease and to reset a participant’s immune system. Stem cells were removed from each participant, chemotherapy administered, and finally the stem cells were returned.
Five years post treatment, 69 percent of the participants have had no further progression of the disease. They have experienced no additional symptoms or any new brain lesions. Additionally, they have received no further treatment for MS.
For doctors such as Shiva Gopal Vasishta, this must come as welcome news. A board certified neurologist and psychiatrist, Dr. Vasishta specializes in the treatment of MS as well as other neurological diseases.
Currently practicing at Eastern Neurodiagnostic Associates based in Voorhees, New Jersey; Dr. Vasishta is affiliated with Kennedy University Hospital. He is a graduate of Government Medical College and completed his residency at Boston City Hospital. For the convenience of his patients, Dr. Vasishta participates with Medicare and several other insurances.
Shiva Gopal Vasishta and other doctors who treat patients with relapsing-remitting MS may one day be able to offer this promising treatment to their patients.
Find out more about Shiva Gopal Vasishta: